Institute of Pharmaceutical Analysis, School of Pharmacy, Lanzhou University, Lanzhou 730030, China.
Int J Mol Sci. 2024 May 29;25(11):5971. doi: 10.3390/ijms25115971.
A dual-emission ratio-fluorescent sensing nanohybrid based on Radix green-synthesized carbon quantum dots (CDs) and glutathione-functionalized gold nanoclusters (GSH-AuNCs) had been developed for the determination of cefodizime sodium (CDZM). The designed fluorescence nanohybrid had two significant fluorescence emission peaks at 458 nm and 569 nm when excited at 360 nm, which was attributed to the CDs and GSH-AuNCs. With the addition of CDZM, the fluorescence at 458 nm was slightly weakened while the fluorescence at 569 nm was enhanced obviously. Based on the relationship between the I/I fluorescence intensity ratio and the concentration of CDZM, the designed nanohybrid exhibited a good linearity range of 1.0-1000.0 μM and the limit of detection (LOD) was 0.19 μM. The method was finally applied in the detection of CDZM in urine, showing the potential applications in complicated biological samples.
基于绿豆合成的碳量子点(CDs)和谷胱甘肽功能化的金纳米簇(GSH-AuNCs)的双发射比率荧光传感纳米杂化体已被开发用于测定头孢地嗪钠(CDZM)。当在 360nm 激发时,设计的荧光纳米杂化体在 458nm 和 569nm 处具有两个显著的荧光发射峰,这归因于 CDs 和 GSH-AuNCs。随着 CDZM 的加入,458nm 处的荧光略有减弱,而 569nm 处的荧光明显增强。基于 I/I 荧光强度比与 CDZM 浓度之间的关系,设计的纳米杂化体表现出良好的线性范围为 1.0-1000.0μM,检测限(LOD)为 0.19μM。该方法最终应用于尿液中 CDZM 的检测,显示了在复杂生物样品中的潜在应用。